These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3459563)

  • 1. Clotting complications of L-asparaginase therapy in children with ALL.
    Cappellato MG; Rosolen A; Zanesco L; Girolami A
    Blut; 1986 Jun; 52(6):377-8. PubMed ID: 3459563
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment.
    Gralnick HR; Henderson E
    Cancer; 1971 Jun; 27(6):1313-20. PubMed ID: 5282618
    [No Abstract]   [Full Text] [Related]  

  • 3. L-Asparaginase-induced coagulopathy during therapy of acute lymphocytic leukemia.
    Sills RH; Nelson DA; Stockman JA
    Med Pediatr Oncol; 1978; 4(4):311-3. PubMed ID: 281595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia.
    Cairo MS; Lazarus K; Gilmore RL; Baehner RL
    J Pediatr; 1980 Nov; 97(5):829-33. PubMed ID: 6933231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia.
    Ramsay NK; Coccia PF; Krivit W; Nesbit ME; Edson JR
    Cancer; 1977 Oct; 40(4):1398-401. PubMed ID: 269003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential changes in platelet function and coagulation in leukemic children treated with L-asparaginase, prednisone, and vincristine.
    Pui CH; Jackson CW; Chesney C; Lyles SA; Bowman WP; Abromowitch M; Simone JV
    J Clin Oncol; 1983 Jun; 1(6):380-5. PubMed ID: 6583320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dural sinus thrombosis in children with acute lymphoblastic leukemia.
    Steinherz PG; Miller LP; Ghavimi F; Allen JC; Miller DR
    JAMA; 1981 Dec; 246(24):2837-9. PubMed ID: 6947095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inefficacy of fresh frozen plasma in the treatment of L-asparaginase-induced coagulation factor deficiencies during ALL induction therapy.
    Nowak-Göttl U; Rath B; Binder M; Hassel JU; Wolff J; Husemann S; Ritter J
    Haematologica; 1995; 80(5):451-3. PubMed ID: 8566890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-asparaginase in blast leukemia].
    Georgiev Z; Genova V; Avramova D
    Vutr Boles; 1973; 12(6):25-37. PubMed ID: 4522152
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coagulation disorders during treatment with l-asparaginase preparations].
    Dobaczewski G
    Wiad Lek; 1998; 51 Suppl 4():227-32. PubMed ID: 10731973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during L-asparaginase therapy.
    Barbui T; Rodeghiero F; Meli S; Dini E
    Acta Haematol; 1983; 69(3):188-91. PubMed ID: 6404103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
    Ettinger LJ; Biener R; Finklestein JZ; Kamalakar P; Jones GR; Avramis VI; Holcenberg JS
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of daily versus weekly L-asparaginase for the treatment of childhood acute leukemia.
    Pratt CB; Simone JV; Zee P; Aur RJ; Johnson WW
    J Pediatr; 1970 Sep; 77(3):474-83. PubMed ID: 5278225
    [No Abstract]   [Full Text] [Related]  

  • 14. L-asparaginase-induced coagulation abnormalities: report of a case.
    Hensley MF
    J Am Osteopath Assoc; 1983 May; 82(9):680-1. PubMed ID: 6575006
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of acute leukemia with the L-asparaginase. Preliminary results based on 84 cases].
    Bernard J; Jacquillat C; Boiron M; Weil M; Bussel A; Larrieu MJ; Delobel J; Goguel A; Levy D; Tanzer J
    Presse Med (1893); 1970 Jan; 78(4):161-6. PubMed ID: 5264814
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acquired deficiencies in antithrombin III and C protein during treatment with L-asparaginase].
    Mielot F; Danel P; Boyer C; Coulombel L; Dommergues JP; Tchernia G; Larrieu MJ
    Arch Fr Pediatr; 1987 Mar; 44(3):161-5. PubMed ID: 2883953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Asparaginase, 1969].
    Boiron M; Levy D
    Pathol Biol (Paris); 1969 Dec; 17(23):1129-32. PubMed ID: 4908018
    [No Abstract]   [Full Text] [Related]  

  • 18. [Monitoring therapy with L-asparaginase. Model of drug-induced antithrombin III deficiency].
    Ranft K; Hammer E; Imhof W; Prager P
    Fortschr Med; 1985 Nov; 103(43):999-1003. PubMed ID: 3867604
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse reactions of L-asparaginase.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1982; 4(3):335-9. PubMed ID: 6959544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia.
    Priest JR; Ramsay NK; Bennett AJ; Krivit W; Edson JR
    J Pediatr; 1982 Jun; 100(6):990-5. PubMed ID: 6953222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.